Defibrillators in heart transplant patients: Not always a shockingly good choice

Affiliations

Editorial

Lynda E Rosenfeld et al. J Cardiovasc Electrophysiol. 2022 Aug.

. 2022 Aug;33(8):1823-1825.

doi: 10.1111/jce.15587. Epub 2022 Jun 11.

¹ Department of Internal Medicine, Section of Cardiovascular Medicine, Yale University School of Medicine, New Haven, Connecticut, USA.

No abstract available

Keywords: implantable defibrillator; orthotopic heart transplant.

Comment on

Implantable cardioverter defibrillators in patients with orthotopic heart transplant: A multicenter case series.
Maskoun W, Raad M, Cha YM, Houmsse M, Abualsuod A, Ezzeddine F, Pieper J, Jamoor K, Tita C, Miller J. Maskoun W, et al. J Cardiovasc Electrophysiol. 2022 Aug;33(8):1813-1822. doi: 10.1111/jce.15588. Epub 2022 Jun 13. J Cardiovasc Electrophysiol. 2022. PMID: 35671363

1. The Antiarrhythmics versus Implantable Defibrillators (AVID) Investigators. A comparison of antiarrhythmic-drug therapy with implantable defibrillators in patients resuscitated from near-fatal ventricular arrhythmias. N Engl J Med. 1997;337:1576-1583.
1. Moss AJ, Zareba W, Hall WJ, et al. Prophylactic implantation of a defibrillator in patients with myocardial infarction and reduced ejection fraction. N Engl J Med. 2002;346:877-883.
1. Bardy GH, Lee KL, Mark DB, et al. Amiodarone or an implantable cardioverter-defibrillator for congestive heart failure. N Engl J Med. 2005;352:225-237.
1. Al-Khatib SM, Stevenson WG, Ackerman MJ, et al. 2017 AHA/ACC/HRS guideline for management of patients with ventricular arrhythmias and the prevention of sudden cardiac death: executive summary. J Am Coll Cardiol. 2018;72:1677-1749.
1. Maskoun W, Raad M, Cha Y-M, et al. Implantable cardioverter defibrillators in patients with orthotopic heart transplant: a multicenter case series. J Cardiovasc Electrophys. 2022.